IEXP chosen as member of the Global Patient Experience Council, launched by The Beryl Institute

Healthcare Leaders to Partner on the Advancement of Human Experience Worldwide

In expanding its commitment to elevate the human experience in healthcare, The Beryl Institute introduces its inaugural Global Council. The Council consists of professionals committed to elevating the conversation on human experience and expanding the global experience movement by collaborating with one another, sharing ideas and growing the global engagement of individuals and organizations in The Beryl Institute Community. Complementing the Institute’s other boards and councils, the Global Council will continually strive to ensure a geographically diverse range of voices are engaged.

The Institute for Patient Experience (IEXP) has been chosen as a leading company in the patient experience since 2016, as part of the Berly Institute project.

«As a global community of practice, ensuring a comprehensive and global view of experience has always been an essential part of what we do,” said Jason A. Wolf, PhD, CPXP, President & CEO, The Beryl Institute. “We also acknowledge we have opportunities as a community to do this better and believe this Council can help shape and lead the global experience conversation.”

Carlos Bezos, CEO of IEXP declared: “We proudly join the Beryl Institute’s initiative. We are convinced that patient experience is evolving far beyond its original conception as patient wellbeing, where the patient is still a passive receptor of care in order to become a key and active element of healthcare process definition, digital health design and pharmaceutical research and adherence protocols.”

Global Council members represent 6 continents and 16 countries and have demonstrated a clear passion for patient experience . They include:

Co-Chairs:

  • Marcelo Alvarenga, President, Brazilian Society of Patient Experience SOBREXP, Brazil
  • Nancy Irene Chan, Director, KK Women’s & Children’s Hospital, Singapore

 Council Members:

  • Maria Elvira Aldeco,Deputy Director of Patient Experience, Fundación Santa Fe de Bogatá, Colombia
  • Nuria Diaz Avendano,Quality Improvement and Patient Experience Leader, Quironsalud, Spain
  • Serena Bertoli-Haley,Quality Improvement and Patient Experience Leader, Vancouver Coastal Health, Canada
  • Carlos Bezos Daleske,CEO, Instituto para la Experiencia del Paciente (IEXP), Spain
  • Aymann Naser Binnaser,HOD, Community Partnership, King Abdullah Medical City, Saudi Arabia
  • Mustafa Bodrick,Professor, Saudi Commission for Health Specialties, Kingdom of Saudi Arabia
  • Pip Brennan,Executive Director, Health Consumers Council (WA) Inc., Australia
  • Hiroko Fujii,Public Relations Manager, Association for Patient Experience Japan, Japan
  • David Grayson,Clinical Lead Patient Experience & Patient Safety, Waitemata District Health Board, New Zealand
  • Anne Marie Hadley,CXO, NSW Health, Australia
  • Sherri Huckstep,Chief Experience Officer, The Royal Women’s Hospital, Australia
  • Ana Kernkraut,Patient Experience Coordinator, Hospital Israelita Albert Einstein, Brazil
  • Amah Kouevi,CEO, French Patient Experience Institute, France
  • David McNally,Head of Experience of Care, NHS England and Improvement, United Kingdom
  • Michal Menashe,Chief Experience Officer, Sheba Medical Center, Israel
  • Muneera Rasheed,Executive Director, Hope Skills Development Organization; Director, Technical Unit, ICON; Student, University of Bergen, Pakistan
  • Kevin Seaman,National Patient Experience Manager, Mediclinic Southern Africa, South Africa
  • Vita Steina,Head of Patient Experience and Customer Service, Children’s University Hospital, Latvia, Latvia
  • Cathy Walsh, Associate Director of Patient Experience, Cheshire and Wirral Partnership Trust, United Kingdom
  • Chatchai Yachantha, Senior Director, Patient Experience, Bumrungrad International Hospital, Thailand
  • Rosanne Zimmerman, Director Patient Experience & Safety, Hamilton Health Sciences, Canada

For more information on the Global Council of The Beryl Institute, visit:

https://www.theberylinstitute.org/GlobalCouncil

Do you want to know more about IEXP? Follow us on our social networks!

###

About The Beryl Institute:

The Beryl Institute is the global community of practice committed to elevating the human experience in healthcare. We believe human experience is grounded in experiences of patients & families, those who work in healthcare and the communities they serve. We define patient experience as the sum of all interactions, shaped by an organization’s culture, that influence patient perceptions across the continuum of care.


Puedes leer más de estos Insights relacionados

Te mantenemos informado con lo último en Experiencia del Paciente

IEXP
De la experiencia a la acción: cómo los pacientes contribuyen a cambiar la atención médica y mejorar los procesos asistenciales

De la experiencia a la acción: cómo los pacientes contribuyen a cambiar la atención médica y mejorar los procesos asistenciales. Trabajar con pacientes en la mejora de procesos asistenciales es una práctica que produce resultados tangibles para el paciente y para el centro de salud. En el reciente 23 congreso de Hospitales organizado por Sedisa […]

IEXP
Opiniones de pacientes y profesionales sanitarios sobre la evaluación clínica a domicilio y a distancia: Un estudio cualitativo estudio cualitativo en España y Brasil. Implicaciones para los ensayos clínicos y la práctica actual.

Cuáles son las necesidades y preferencias de pacientes y profesionales sanitarios (HCP) en España y Brasil en relación con los ensayos clínicos remotos y a domicilio, así como el impacto de los ensayos clínicos descentralizados. Fuente: Haga click en el siguiente enlace de Springer.com

IEXP
Apoyar el lanzamiento de terapias en la experiencia de los pacientes – el caso de la EPOC

La experiencia del paciente es un conocimiento esencial para diseñar estrategias de prescripción centrada en la persona. Éstas son una herramienta clave en el lanzamiento de nuevas terapias, especialmente a medida que las patologías evolucionan y la complejidad clínica de la persona incrementa, cuando se trata de terapias nuevas, por ejemplo, terapias génicas, o se produce […]

Solicitamos su permiso para obtener datos estadísticos de su navegación en esta web, en cumplimiento del Real Decreto-ley 13/2012. Si continúa navegando consideramos que acepta el uso de cookies. OK | Más información